content:zonisamide

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
Next revisionBoth sides next revision
content:zonisamide [2020/02/13 15:58] – [Zonisamide] icnacontent:zonisamide [2020/02/23 22:55] – [Zonisamide] icna
Line 1: Line 1:
 ====== Zonisamide ====== ====== Zonisamide ======
 +Zonisamide is a synthetic 1,2-benzisoxazole derivative (1,2-benzisoxazole-3-methanesulfonamide). It is chemically classified as a sulfonamide with a structural similarity to serotonin. It was first introduced as an AED in Japan in 1989.
 ===== Authorised indications ===== ===== Authorised indications =====
  
Line 27: Line 27:
  
 **Reference range:** 15–40 mg/l (45–180 μmol/l). **Reference range:** 15–40 mg/l (45–180 μmol/l).
 +
 +see [[https://bnfc.nice.org.uk/drug/zonisamide.html|Zonisamide in the British National Formulary]]
  
 ==== Main ADRs ==== ==== Main ADRs ====
Line 74: Line 76:
  
 ==== References ==== ==== References ====
-~~refnotes cite~~+~~REFNOTES~~ 
 +~~AUTHORS~~ 
 +{{tag>pharmacopoeia}}
  • content/zonisamide.txt
  • Last modified: 2022/04/30 18:38
  • by administrator@icnapedia.org